Manufacturer
Sun Pharmaceutical Industries Ltd.
Contents
Pantoprazole
Indication
Zollinger-Ellison syndrome/ Gastro-oesophageal reflux disease, Peptic ulcer
Instruction
Administer via slow injection or short-term infusion over 2-15 minutes. Switch to oral therapy as soon as possible.
Drug interaction
May decrease plasma concentrations of rilpivirine and atazanavir. Increased risk of hypomagnesaemia with diuretics. Increased risk of digoxin-induced cardiotoxic effects. May increase INR and prothrombin time of warfarin. May increase plasma concentration of methotrexate. May decrease absorption of itraconazole, ketoconazole, posaconazole, erlotinib. May diminish the therapeutic effect of clopidogrel.
Malaysia
